المؤلفون: Liu WD; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan. Electronic address: b95401043@ntu.edu.tw., Lin MS; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: mslin1221@ntu.edu.tw., Sun HY; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hysun13@gmail.com., Shih MC; School of Medicine, National Tsing Hua University, Hsinchu, Taiwan. Electronic address: mcshih@gms.ndhu.edu.tw., Chuang YC; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: weischuang@gmail.com., Huang YS; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: b101091021@gmail.com., Lin KY; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Center of Infection Control, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: kuanyin0828@gmail.com., Li GC; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: ligc2020n@gmail.com., Wu PY; Center of Infection Control, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: wpei.ying@msa.hinet.net., Chen LY; Center of Infection Control, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: pazigid@ntuh.gov.tw., Liu WC; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: lwj0925@gmail.com., Su YC; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: echinsu@gmail.com., He PC; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: vicky90180@gmail.com., Chen YT; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: et771205@gmail.com., Lin CY; Department of Nursing, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: 107545@ntuh.gov.tw., Cheng YC; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: xking54647@gmail.com., Yao Y; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: mouse.ohya@gmail.com., Yeh YC; Department of Nursing, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: r08426007@ntu.edu.tw., Liu CC; Department of Nursing, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: kendochi@yahoo.com.tw., Pan MY; Department of Nursing, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: 007520@ntuh.gov.tw., Luo YZ; Center of Infection Control, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: ruru987654321@hotmail.com., Chang HY; Center of Infection Control, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: a0956180125@gmail.com., Wang JT; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan. Electronic address: wang.jt1968@gmail.com., Sheng WH; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: whsheng@ntu.edu.tw., Hsieh SM; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsmaids@hotmail.com., Chang SY; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: sychang@ntu.edu.tw., Hung CC; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hcc0401@ntu.edu.tw.

المصدر: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2024 Aug; Vol. 57 (4), pp. 554-563. Date of Electronic Publication: 2024 Feb 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: published by Elsevier for the Taiwan Society of Microbiology Country of Publication: England NLM ID: 100956211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1995-9133 (Electronic) Linking ISSN: 16841182 NLM ISO Abbreviation: J Microbiol Immunol Infect Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/immunology , Antibodies, Viral*/blood , HIV Infections*/immunology , Spike Glycoprotein, Coronavirus*/immunology , BNT162 Vaccine*/administration & dosage , BNT162 Vaccine*/immunology , SARS-CoV-2*/immunology , Immunoglobulin G*/blood , 2019-nCoV Vaccine mRNA-1273*/immunology , 2019-nCoV Vaccine mRNA-1273*/administration & dosage , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Adult ; Vaccination/methods ; Vaccine Efficacy ; Seroconversion

المؤلفون: John TJ; Christian Medical College, Vellore, Tamil Nadu, India., Dharmapalan D; Apollo Hospitals, CBD Belapur, Navi Mumbai, India., Hirschhorn N; Independent Consultant, Minneapolis, MN, USA.

المصدر: Infectious diseases (London, England) [Infect Dis (Lond)] 2024 Aug; Vol. 56 (8), pp. 669-677. Date of Electronic Publication: 2024 Jun 18.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101650235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-4243 (Electronic) Linking ISSN: 23744243 NLM ISO Abbreviation: Infect Dis (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: Poliomyelitis*/prevention & control , Poliomyelitis*/immunology , Poliomyelitis*/transmission , Poliovirus Vaccine, Oral*/immunology , Poliovirus Vaccine, Oral*/administration & dosage , Disease Eradication* , Poliovirus*/immunology , Immunity, Mucosal*, Humans ; Intestinal Mucosa/immunology ; Intestinal Mucosa/virology ; Poliovirus Vaccine, Inactivated/immunology ; Poliovirus Vaccine, Inactivated/administration & dosage ; Vaccination

المؤلفون: Jiménez-Sepúlveda N; Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Gras-Valentí P; Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; Preventive Medicine and Public Health Area, Faculty of Health Sciences, University of Alicante, Alicante, Spain., Chico-Sánchez P; Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; Preventive Medicine and Public Health Area, Faculty of Health Sciences, University of Alicante, Alicante, Spain. Electronic address: pablochico@pablochico.es., Castro-García JM; Thoracic Imaging Division, Saint Michael's Hospital, Toronto, Canada., Ronda-Pérez E; Preventive Medicine and Public Health Area, Faculty of Health Sciences, University of Alicante, Alicante, Spain; Centre of Networked Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Vanaclocha H; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain., Peiró S; Foundation for the Promotion of Health and Biomedical Research of the Valencian, Community (FISABIO), Valencia, Spain., Burgos JS; General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain., Ana Berenguer; General Directorate of Analysis and Public Policy, Valencia Government, Valencia, Spain., Navarro D; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain., Sánchez-Payá J; Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.

مؤلفون مشاركون: Valencian vaccine research program ProVaVac study group

المصدر: Vaccine [Vaccine] 2024 Jul 25; Vol. 42 (19), pp. 4011-4021. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/epidemiology , Health Personnel* , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , Hospitalization*/statistics & numerical data , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , BNT162 Vaccine*/immunology , BNT162 Vaccine*/administration & dosage , Immunization, Secondary* , Vaccine Efficacy*, Humans ; Spain/epidemiology ; Male ; Female ; Adult ; Middle Aged ; Case-Control Studies ; 2019-nCoV Vaccine mRNA-1273/immunology ; Vaccination/methods

SCR Organism: SARS-CoV-2 variants

المؤلفون: Jongkees MJ; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases., Tan NH; Department of Hospital Pharmacy., Geers D; Department of Viroscience., de Vries RD; Department of Viroscience., GeurtsvanKessel CH; Department of Viroscience., Hensley KS; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases., Sablerolles RSG; Department of Hospital Pharmacy., Bogers S; Department of Viroscience., Gommers L; Department of Viroscience., Blakaj B; Department of Medical Oncology., Miranda Afonso P; Department of Biostatistics and Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands., Hansen BE; Department of Biostatistics and Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Institute of Health Policy, Management and Evaluation, University of Toronto.; Toronto Centre for Liver Disease, Toronto General Hospital University Health Network, Toronto, Canada., Rijnders BJA; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases., Brinkman K; Department of Internal Medicine and Infectious Diseases, OLVG Hospital, Amsterdam., van der Kuy PHM; Department of Hospital Pharmacy., Roukens AHE; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, the Netherlands., Rokx C; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases.

المصدر: AIDS (London, England) [AIDS] 2024 Jul 15; Vol. 38 (9), pp. 1355-1365. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: Immunization, Secondary* , HIV Infections*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , Immunogenicity, Vaccine* , Antibodies, Viral*/blood , Antibodies, Viral*/immunology , BNT162 Vaccine*/immunology , BNT162 Vaccine*/administration & dosage , SARS-CoV-2*/immunology, Humans ; Male ; Middle Aged ; Female ; Prospective Studies ; Netherlands ; Adult ; 2019-nCoV Vaccine mRNA-1273/immunology ; 2019-nCoV Vaccine mRNA-1273/administration & dosage ; Cytokines/immunology ; Aged

المؤلفون: Gillot C; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium., Tré-Hardy M; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium; Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium., Cupaiolo R; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Blairon L; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Wilmet A; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Beukinga I; Department of Laboratory Medicine, Hopital Iris Sud, Brussels, Belgium., Dogné JM; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium., Douxfils J; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Qualiblood s.a., Research and Development Department, Namur, Belgium. Electronic address: jonathan.douxfils@unamur.be., Favresse J; Department of Pharmacy, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.

المصدر: Virology [Virology] 2024 Jul; Vol. 595, pp. 110082. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0110674 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0341 (Electronic) Linking ISSN: 00426822 NLM ISO Abbreviation: Virology Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Neutralizing*/immunology , Antibodies, Neutralizing*/blood , 2019-nCoV Vaccine mRNA-1273*/immunology , 2019-nCoV Vaccine mRNA-1273*/administration & dosage , COVID-19*/immunology , COVID-19*/virology , COVID-19*/prevention & control , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , Health Personnel* , Immunization, Secondary* , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage, Humans ; Male ; Female ; Adult ; Middle Aged ; BNT162 Vaccine/administration & dosage ; BNT162 Vaccine/immunology ; Spike Glycoprotein, Coronavirus/immunology ; Spike Glycoprotein, Coronavirus/genetics ; Breakthrough Infections

SCR Disease Name: COVID-19 breakthrough infections

SCR Organism: SARS-CoV-2 variants

المؤلفون: Figueroa AL; Moderna, Cambridge, Massachusetts, USA., Azzi JR; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Eghtesad B; Cleveland Clinic, Cleveland, Ohio, USA., Priddy F; Moderna, Cambridge, Massachusetts, USA., Stolman D; Moderna, Cambridge, Massachusetts, USA., Siangphoe U; Moderna, Cambridge, Massachusetts, USA., Leony Lasso I; Moderna, Cambridge, Massachusetts, USA., de Windt E; Moderna, Cambridge, Massachusetts, USA., Girard B; Moderna, Cambridge, Massachusetts, USA., Zhou H; Moderna, Cambridge, Massachusetts, USA., Miller JM; Moderna, Cambridge, Massachusetts, USA., Das R; Moderna, Cambridge, Massachusetts, USA.

المصدر: The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. e591-e600.

نوع المنشور: Journal Article; Clinical Trial, Phase III

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: 2019-nCoV Vaccine mRNA-1273*/administration & dosage , 2019-nCoV Vaccine mRNA-1273*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , Transplant Recipients* , Antibodies, Neutralizing*/blood , Antibodies, Viral*/blood , SARS-CoV-2*/immunology , COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , Organ Transplantation*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Adult ; Aged ; Immunogenicity, Vaccine ; Liver Transplantation/adverse effects ; Kidney Transplantation/adverse effects ; Vaccination/adverse effects ; Immunocompromised Host

المؤلفون: Pather S; BioNTech SE, Mainz, Germany., Charpentier N; BioNTech SE, Mainz, Germany., van den Ouweland F; BioNTech SE, Mainz, Germany., Rizzi R; BioNTech SE, Mainz, Germany., Finlayson A; BioNTech SE, Mainz, Germany., Salisch N; BioNTech SE, Mainz, Germany., Muik A; BioNTech SE, Mainz, Germany., Lindemann C; BioNTech SE, Mainz, Germany., Khanim R; BioNTech SE, Mainz, Germany., Abduljawad S; BioNTech SE, Mainz, Germany., Smith ER; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Gurwith M; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.

مؤلفون مشاركون: Benefit-Risk Assessment of VAccines by TechnolOgy Working Group (BRAVATO; ex-V3SWG)

المصدر: Vaccine [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126165. Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , COVID-19*/prevention & control , BNT162 Vaccine*/immunology , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , mRNA Vaccines*, Humans ; Risk Assessment ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/immunology ; Immunogenicity, Vaccine

SCR Organism: SARS-CoV-2 variants

المؤلفون: Derrick SC; Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA. Electronic address: steven.derrick@fda.hhs.gov., Yang A; Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Cowley S; Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.

المصدر: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2024 Sep; Vol. 148, pp. 102540. Date of Electronic Publication: 2024 Jul 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 100971555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-281X (Electronic) Linking ISSN: 14729792 NLM ISO Abbreviation: Tuberculosis (Edinb) Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-17*/metabolism , BCG Vaccine*/immunology , Lung*/immunology , Lung*/microbiology , Lung*/metabolism , Mice, Inbred C57BL* , Adjuvants, Immunologic*/pharmacology , Mycobacterium tuberculosis*/immunology, Animals ; Female ; Disease Models, Animal ; Quaternary Ammonium Compounds/pharmacology ; Adjuvants, Vaccine ; CD4-Positive T-Lymphocytes/immunology ; Mice, Knockout ; Tuberculosis, Pulmonary/immunology ; Tuberculosis, Pulmonary/prevention & control ; Vaccine Efficacy ; Mice ; Glycolipids

المؤلفون: Poh XY; National Centre for Infectious Diseases, Singapore., Lee IR; National Centre for Infectious Diseases, Singapore., Tan CW; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Chavatte JM; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Fong SW; A∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (A∗STAR), Singapore, 138648, Singapore., Goh YS; A∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (A∗STAR), Singapore, 138648, Singapore., Rouers A; A∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (A∗STAR), Singapore, 138648, Singapore., Wong N; A∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (A∗STAR), Singapore, 138648, Singapore., Torres-Ruesta A; A∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (A∗STAR), Singapore, 138648, Singapore., Mah SYY; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore., Yeoh AYY; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore., Gandhi M; Biostatistics, Singapore Clinical Research Institute, Singapore; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore., Rahman N; Biostatistics, Singapore Clinical Research Institute, Singapore; Saw Swee Hock School of Public Health, Singapore., Chin YQ; National Centre for Infectious Diseases, Singapore., Lim JJ; National Centre for Infectious Diseases, Singapore., Yoong TJK; National Centre for Infectious Diseases, Singapore., Rao S; National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore., Chia PY; National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Ong SWX; National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore., Lee TH; National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore., Sadarangani SP; National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Lin RJH; National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore., Lim DRX; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Chia W; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore., Renia L; A∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (A∗STAR), Singapore, 138648, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore., Ren EC; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore Immunology Network, Singapore., Lin RTP; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Lye DC; National Centre for Infectious Diseases, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Wang LF; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore., Ng LFP; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; A∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (A∗STAR), Singapore, 138648, Singapore. Electronic address: lisa_ng@IDLabs.a-star.edu.sg., Young BE; National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. Electronic address: Barnaby_young@ncid.sg.

المصدر: EBioMedicine [EBioMedicine] 2024 Sep; Vol. 107, pp. 105275. Date of Electronic Publication: 2024 Aug 12.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , Immunization, Secondary* , BNT162 Vaccine*/immunology , BNT162 Vaccine*/administration & dosage , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , 2019-nCoV Vaccine mRNA-1273*/immunology, Humans ; Male ; Female ; Adult ; Middle Aged ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/blood ; Immunogenicity, Vaccine ; Immunity, Humoral ; Vaccination/methods ; Aged ; Spike Glycoprotein, Coronavirus/immunology ; Young Adult ; Breakthrough Infections

SCR Disease Name: COVID-19 breakthrough infections

SCR Organism: SARS-CoV-2 variants

المؤلفون: Wagenhäuser I; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, 97080, Germany; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, 97080, Germany., Almanzar G; Pediatric Rheumatology/Special Immunology / Department of Pediatrics, University Hospital Würzburg, Würzburg, 97080, Germany., Förg FB; Pediatric Rheumatology/Special Immunology / Department of Pediatrics, University Hospital Würzburg, Würzburg, 97080, Germany., Stein A; Pediatric Rheumatology/Special Immunology / Department of Pediatrics, University Hospital Würzburg, Würzburg, 97080, Germany., Eiter I; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, 97080, Germany., Reusch J; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, 97080, Germany; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, 97080, Germany., Mees J; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, 97080, Germany., Herzog A; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, 97080, Germany., Vogel U; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, 97080, Germany; Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, 97080, Germany., Frey A; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, 97080, Germany., Lâm TT; Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, 97080, Germany., Schubert-Unkmeir A; Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, 97080, Germany., Dölken L; Institute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, 97080, Germany., Kurzai O; Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, 97080, Germany; Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knoell-Institute, Jena, 07745, Germany., Frantz S; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, 97080, Germany., Gabel A; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, 97080, Germany., Petri N; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, 97080, Germany., Prelog M; Pediatric Rheumatology/Special Immunology / Department of Pediatrics, University Hospital Würzburg, Würzburg, 97080, Germany. Electronic address: martina.prelog@uni-wuerzburg.de., Krone M; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, 97080, Germany; Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, 97080, Germany.

المصدر: Vaccine [Vaccine] 2024 Aug 30; Vol. 42 (21), pp. 126132. Date of Electronic Publication: 2024 Jul 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Spike Glycoprotein, Coronavirus*/immunology , Health Personnel* , COVID-19*/prevention & control , COVID-19*/immunology , BNT162 Vaccine*/immunology , SARS-CoV-2*/immunology , Antibodies, Viral*/blood , Antibodies, Viral*/immunology , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , Immunity, Cellular*/immunology, Humans ; Female ; Male ; Middle Aged ; Adult ; 2019-nCoV Vaccine mRNA-1273/immunology ; Vaccination/methods ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Immunogenicity, Vaccine ; T-Lymphocytes/immunology ; B-Lymphocytes/immunology